Evicenter
P&T meetings

Duravyu (vorolanib intravitreal insert)

Wet age-related macular degeneration

Also known as EYP-1901
Manufacturer
EyePoint
Launch
Not announced
Last updated
136 sources

Product information and disease descriptionProduct descriptionProduct information

Special populations

4 evidence topics · 2 sources

Older adults: LUGANO baseline age
CharacteristicDURAVYU 2.7 mg (n=211)Aflibercept 2 mg q8W (n=216)
Age (years), mean (SD)“77.5 (7.52)”“77.0 (7.61)”
Age ≥ 65, n (%)“202 (95.7)”“205 (94.9)”
Female, n (%)“136 (64.5)”“141 (65.3)”
Pediatric use, hepatic impairment, and renal impairment

No evidence found.